Terraform Labs was ‘built on lies’ SEC says as civil trial nears end By Reuters
[ad_1] By Jody Godoy (Reuters) -An attorney for the U.S. Securities and Exchange Commission told a jury in Manhattan on Friday that Terraform Labs and...
Tesla to give one month driver-assist technology trial for customers By Reuters
[ad_1] © Reuters. FILE PHOTO: The Tesla logo is seen on a car in Los Angeles, California, U.S., July 9, 2020. REUTERS/Lucy Nicholson/File Photo By...
Acelyrin reports positive early trial results for TED therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Acelyrin Inc. (NASDAQ:SLRN), a biopharmaceutical company specializing in immunology treatments, has announced promising early results from its Phase 1/2...
Neurogene expands Rett syndrome trial, doses third patient By Investing.com
[ad_1] © Reuters. NEW YORK – Neurogene Inc. (NASDAQ: NGNE), a biotechnology firm focused on developing genetic therapies for rare neurological diseases, announced today that...
BioLineRx begins phase 2 trial for pancreatic cancer treatment By Investing.com
[ad_1] © Reuters. TEL AVIV – BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical company, has initiated the Phase 2 CheMo4METPANC clinical trial, dosing the...
Dianthus advances DNTH103 in Phase 2 trial for gMG By Investing.com
[ad_1] © Reuters. NEW YORK and WALTHAM, Mass. – Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a biotechnology firm focused on autoimmune disease therapies, announced the start...
H.C. Wainwright downgrades RAPT shares to neutral after clinical trial halt By Investing.com
[ad_1] © Reuters. On Wednesday, RAPT Therapeutics (NASDAQ:) faced a downgrade from H.C. Wainwright, moving from Buy to Neutral, following a pause in all clinical...
US judge sets October 2026 trial for FTC antitrust suit against Amazon By Reuters
[ad_1] © Reuters. FILE PHOTO: The logo of Amazon is seen at the company’s logistics centre in Boves, France, October 6, 2021 REUTERS/Pascal Rossignol/File Photo...
Puma Biotech starts phase II trial for lung cancer therapy By Investing.com
[ad_1] © Reuters. LOS ANGELES – Puma Biotechnology, Inc. (NASDAQ: NASDAQ:) has commenced a Phase II clinical trial to evaluate the efficacy of its drug...
Ocular Therapeutix advances wet AMD treatment with Phase 3 trial By Investing.com
[ad_1] © Reuters. BEDFORD, Mass. – Ocular Therapeutix, Inc. (NASDAQ:) has reached a significant milestone in the development of its innovative wet age-related macular degeneration...